1. Trang chủ
  2. » Luận Văn - Báo Cáo

Tài liệu Báo cáo khoa học: Unique features of recombinant heme oxygenase of Drosophila melanogaster compared with those of other heme oxygenases studied docx

12 453 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Tiêu đề Unique features of recombinant heme oxygenase of Drosophila melanogaster compared with those of other heme oxygenases studied
Tác giả Xuhong Zhang, Michihiko Sato, Masanao Sasahara, Catharina T. Migita, Tadashi Yoshida
Trường học Yamagata University
Chuyên ngành Biochemistry
Thể loại scientific report
Năm xuất bản 2004
Thành phố Japan
Định dạng
Số trang 12
Dung lượng 645,57 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

The purified DmDHO degraded hemin to biliverdin, CO and iron in the presence of reducing systems such as NADPH/cytochrome P450 reductase and sodium ascorbate, although the reaction rate w

Trang 1

Unique features of recombinant heme oxygenase of Drosophila

oxygenases studied

Xuhong Zhang1, Michihiko Sato2, Masanao Sasahara1, Catharina T Migita3and Tadashi Yoshida1

1

Department of Biochemistry and2Central Laboratory for Research and Education, Yamagata University School of Medicine, Japan;

3

Department of Biological Chemistry, Faculty of Agriculture, Yamaguchi University, Japan

We cloned a cDNA for a Drosophila melanogaster

homo-logue of mammalian heme oxygenase (HO) and constructed

a bacterial expression system of a truncated, soluble form

of D melanogaster HO (DmDHO) The purified DmDHO

degraded hemin to biliverdin, CO and iron in the presence

of reducing systems such as NADPH/cytochrome P450

reductase and sodium ascorbate, although the reaction rate

was slower than that of mammalian HOs Some properties

of DmHO, however, are quite different from other known

HOs Thus DmDHO bound hemin stoichiometrically to

form a hemin–enzyme complex like other HOs, but this

complex did not show an absorption spectrum of

hexa-coordinated heme protein The absorption spectrum of the

ferric complex was not influenced by changing the pH of the

solution Interestingly, an EPR study revealed that the iron

of heme was not involved in binding heme to the enzyme Hydrogen peroxide failed to convert it into verdoheme A spectrum of the ferrous–CO form of verdoheme was not detected during the reaction from hemin under oxygen and

CO Degradation of hemin catalyzed by DmDHO yielded three isomers of biliverdin, of which biliverdin IXa and two other isomers (IXb and IXd) accounted for 75% and 25%, respectively Taken together, we conclude that, although DmHO acts as a real HO in D melanogaster, its active-site structure is quite different from those of other known HOs Keywords: biliverdin; Drosophila melanogaster; heme oxy-genase; insect; NADPH/cytochrome P450 reductase

Heme oxygenase (HO, EC 1.14.99.3) was first characterized

in mammals as a microsomal enzyme that catalyzes the

three-stepoxidation of hemin to biliverdin IXa, CO, and

free iron, via a-meso-hydroxyhemin, verdoheme, and ferric

iron–biliverdin complex [1–3] (Scheme 1) To date two

mammalian isozymes of HO have been identified [4]: HO-1,

an inducible enzyme that is highly expressed in the spleen

and liver; HO-2, a constitutive enzyme found abundantly in

the brain and testes The two isozymes have about 43%

similarity at amino acid level, and both have a C-terminal

hydrophobic domain that is involved in binding to

micro-somal membrane Both HO-1 and HO-2 have been

demonstrated to play important roles in physiological iron

homeostasis [5,6], antioxidant defense [7,8], and possibly the cGMP signaling pathway [9,10] Although HO-3 was once reported as an isozyme of HO, its function is not yet well defined [11]

HO has also been found and characterized in bacteria [12–14] and plants [15–18] and other species such as Rhodophyta [19] In contrast with mammalian HO, these HOs are water-soluble enzymes because they lack

a membrane-anchoring domain at the C-termini of their sequences In pathogenic bacteria, HO is thought to help bacteria to acquire iron from heme-containing proteins found in their host cells for survival and toxin production

In plants, biliverdin is used for the biosynthesis of photo-responsive bilins such as phycobilins and phytochromobi-lins [15–19] Although the HOs have been characterized structurally and functionally in most species, very little is known about HO in insects

Heme is extremely important in insects It is a vital nutrient for most, if not all, insects for their embryonic development [20], although they do not use it as a transport vehicle or storage vessel for oxygen Heme also serves as the prosthetic moiety of hemoproteins, such as hemoglobin [21,22], catalase [23] and nitric oxide synthase [24], which are essential for biological function However, heme is poten-tially toxic to insects, particularly blood-sucking insects such

as mosquitoes, because it catalyzes oxidative reactions that can damage membranes and destroy nucleic acids There-fore, insects are thought to have several mechanisms for sequestering and controlling heme For example, it can be conjugated with such proteins as the heme binding protein

Correspondence to T Yoshida, Department of Biochemistry,

Yamagata University School of Medicine, Yamagata, Japan.

Fax: + 81 23 628 5225, Tel.: + 81 23 628 5222,

E-mail: tyoshida@med.id.yamagata-u.ac.jp

Abbreviations: HO, heme oxygenase; CPR, NADPH/cytochrome

P450 reductase; DmHO, heme oxygenase of D melanogaster;

DmDHO, truncated form of D melanogaster heme oxygenase;

DmCPR, NADPH/cytochrome P450 reductase of D melanogaster;

DmDCPR, truncated form of D melanogaster NADPH/cytochrome

P450 reductase; Syn HO-1, heme oxygenase-1 of Synechocistis sp.

PCC 6803.

Enzymes: heme oxygenase (EC 1.14.99.3); NADPH/cytochrome P450

reductase (EC 1.6.2.4).

(Received 25 December 2003, revised 2 March 2004,

accep ted 9 March 2004)

Trang 2

isolated from the bug Rhodnius prolixus, to form complexes

that serve as a source of heme and prevent cells from

heme-induced oxidative injury [25]

Although heme biosynthesis has been reported in

insects, very little is known about its degradation In fact,

no HO has been isolated and characterized from any

insect species so far Interestingly, biliverdin IXc is present

in larval integument and hemolymph in some species of

Lepidoptera, such as Pieris brassica [26], Manduca sexta

[27], and Samia cynthia ricini [28] These insects possibly

possess a HO that selectively cleaves the c-meso site from

heme However, biliverdin IXa, the isomer formed in

humans, occurs in the hemolymph and integument of

other insects [29]

Throughout the last century, the fruit fly has been the

workhorse for genetic studies in eukaryotes The recent

decoding of the complete genome sequence of Drosophila

melanogaster has provided us with the opportunity to

identify all fruit fly genes, including those involved in heme

metabolism [30] In the present study, we found a putative

HO gene in D melanogaster by homology searching in

FlyBase, a database of genetic and molecular data for the

fruit fly The D melanogaster HO gene without the sequence

coding for the last 21 amino acids was cloned and further

expressed in Escherichia coli The truncated enzyme was

obtained in high yield as a soluble, catalytically active

protein, making it available for the first time for detailed

mechanistic studies

Experimental procedures

cDNA cloning and expression of putative DmHO

FlyBase shows the existence of a nucleotide sequence

encoding a protein homologous to both human and rat

HOs RT-PCR was used to prepare cDNA encoding the

putative HO of D melanogaster Briefly, first-strand cDNA

synthesis was performed at 42C for 60 min using adult

D melanogasterpolyA-rich RNA (Clontech) as a template,

oligo(dT) primer (Genset, Proligo Japan, Kyoto, Japan),

and reverse transcriptase (ReverTra Ace; Toyobo, Osaka,

Japan) The synthesized cDNA was subjected to PCR amplification to generate the coding region of the putative

D melanogasterHO (DmHO) A sense primer, DmHOF1 (5¢-GCGCAAAAGACATATGTCAGCGAGCGAAG-3¢) and an antisense primer, DmHOR1 (3¢-CGAGAGTTC ATTCTTTTCGAACTTTATG-5¢) were used to amp lify the full length DmHO consisting of 296 amino acid residues The underlined nucleotide sequence of 5¢-CATATG-3¢ represents the NdeI recognition site involving an initiation codon The underlined nucleotide sequences of 3¢-ATT-5¢, and 3¢-TTCGAA-5¢ are the complementary sequences of a stopcodon, and the HindIII recognition site, respectively Another primer set with DmHOF1 and antisense primer DmHOR2 (3¢-GCACGGTTAGAAATCTTCGAACGG GAGCGT-5¢) were used to prepare a truncated form of DmHO (DmDHO) which lacks a C-terminal hydrophobic domain consisting of 21 amino acid residues The underlined nucleotide sequence of 3¢-ATC-5¢ is the complementary sequences of a stopcodon PCR amplification was carried out with AmpliTaq Gold (Applied Biosystems) for 30 cycles The PCR products were digested with NdeI and HindIII and then cloned into the NdeI and HindIII sites of the pMW172 expression vector The constructs encoding the full length and C-terminally truncated DmHO were named pMWDmHO and pMWDmDHO, respectively Both con-structs were sequenced using the dye terminator cycle sequencing method

Purification of recombinant DmDHO

E coli strain BL21 (DE3) was transformed with pMWDmDHO A single colony was picked up and precultured in 5 mL Luria–Bertani medium containing

50 lgÆmL)1ampicillin and 1% glucose at 37C overnight Then 200 lL of the preculture was added to 500 mL of the same medium for incubation at 37C After the A600

of the culture reached about 1.0, the incubation was continued at 20C for 24 h The harvested cells were washed with 20 mMpotassium phosphate buffer, pH 7.4, containing 134 mMKCl, resuspended in 9 vols (9 mL per g

E coli cells) 50 m Tris/HCl buffer (pH 7.4) containing

Scheme 1 Heme degradation pathway Heme

to biliverdin IXa catalyzed by HO and verdin IXa to bilirubin IXa catalyzed by bili-verdin reductase.

Trang 3

2 mM EDTA, and lysed by lysozyme (final concentration

0.2 mgÆmL)1) for 30 min at 4C The lysed cells were

briefly sonicated and centrifuged at 100 000 g for 60 min;

the resulting supernatant was used as the soluble fraction

For the purification, the soluble fraction was first

subjected to ammonium sulfate fractionation The

preci-pitate obtained at 33–55% saturation was collected by

centrifugation, dissolved in 20 mM potassium phosphate

buffer (pH 7.4) in a final volume of 5 mL, and applied to

a column (3.6· 50 cm) of Sephadex G-75,

pre-equili-brated with the same buffer Fractions with an intense

32 kDa band on SDS/PAGE were collected and applied

to a DEAE-cellulose DE-52 column (2.6· 30 cm) After

the column had been washed with 50 mL 20 mM

potas-sium phosphate buffer (pH 7.4) containing 100 mM KCl,

the protein was eluted with 400 mL 20 mM potassium

phosphate buffer (pH 7.4) with a linear gradient of 100–

400 mM KCl The fractions containing 32 kDa protein

were then fractionated with a hydroxyapatite column

(2.6· 20 cm), using a linear gradient between 200 mL

each 20 and 300 mM potassium phosphate buffer

(pH 7.4) All fractions containing the 32 kDa protein

were pooled and concentrated The buffer solution was

changed to 50 mM potassium phosphate buffer (pH 7.4)

by Sephadex G-25 column chromatography All

proce-dures were conducted at 4C, and the final products were

stored at)80 C

Construction of DmDCPR expression plasmid

A truncated form of NADPH/cytochrome P450 reductase

of D melanogaster (DmDCPR) expression vector was

constructed by the same method as described above An

NdeI/HindIII cDNA fragment encoding amino acids

46–679 of DmCPR was amplified by RT-PCR using

the primers DmCPRF1 (5¢-CTTCCTGCGTACGCA

TATGAAGGAGGAGGA-3¢) and DmCPRR1 (3¢-CA

GACCTCGATTCGAATAGGTTTTCGGTTG-5¢) The

first 45 amino acids of DmCPR were deleted because this

sequence involves a membrane-bound region One NdeI

restriction site inside the target sequence was reduced by

site-directed mutagenesis without changing any amino acid

residues The PCR product was digested and inserted into

the NdeI and HindIII restriction sites of pMW172 to form

pMWDmDCPR

Preparation and assay of DmDCPR

Conditions for expressing DmDCPR and preparing a

soluble fraction were similar to those for DmDHO described

above The precipitate obtained from the soluble fraction

at 40–65% ammonium sulfate saturation was suspended

in 15 vols (15 mL per g E coli cells) 20 mM potassium

phosphate buffer (pH 7.4) The suspension was applied to a

DE-52 column and the protein was eluted with a 400 mL

linear gradient of 100–400 mM KCl in 20 mM potassium

phosphate buffer (pH 7.4) Yellow fractions with an intense

72 kDa band on SDS/PAGE were pooled and then loaded

on a column of 2¢5¢-ADP Sepharose 4B (Amersham

Pharmacia Biotech) The column was washed with 50 mL

0.1Mpotassium phosphate buffer (pH 7.4), and DmDCPR

was eluted with 20 mL 0.1Mpotassium phosphate buffer

(pH 7.4) containing 7 mgÆmL)1 2¢(3¢)-AMP Finally, the 2¢(3¢)-AMP in the eluate was removed by passage through a Sephadex G-25 column The final products were stored in 50% glycerol at)80 C

The ability of DmDCPR to catalyze reduction of 2,6-dichloroindophenol was assayed using 21 mM )1Æcm)1as the absorption coefficient of the dye at 600 nm [31]

Heme binding study Heme binding of DmDHO was tested by adding hemin to

12 lM DmDHO in 2 mL 50 mM potassium phosphate buffer (pH 7.4) The reference cuvette contained 2 mL

50 mM potassium phosphate buffer (pH 7.4) alone A solution of 1 mMhemin was added in 4 lL aliquots to both test and reference cuvettes with 5 min equilibration between additions at 25C The absorbance between 350 and

750 nm was measured on a Beckman DU7400 single-beam spectrophotometer

Assay of DmDHO by measuring bilirubin formation The catalytic activity of DmDHO was determined after conversion of biliverdin IXa, produced by the enzyme, into bilirubin by biliverdin IXa reductase The NADPH/ DmDCPR reaction mixture contained in a final volume

of 1.5 mL: 50 mM potassium phosphate buffer (pH 7.4),

26 lMhemin, 1 lMDmDHO, 0.22 lMDmDCPR, 300 lM NADPH, and 6 lM biliverdin reductase [32] NADPH was omitted from the control system When necessary,

1 mMdesferrioxamine was added to both the reaction and control systems The reaction was started by the addition

of NADPH after 3 min preincubation at 37C, and monitored at 468 nm for 10 min The value of 43.5 mM )1Æcm)1 was used as the absorption coefficient for bilirubin at 468 nm [33] The ascorbate system contained in a final volume of 1.5 mL: 50 mMpotassium phosphate buffer (pH 7.4), 26 lM hemin, 1 lMDmDHO,

50 mM sodium ascorbate, 60 lM NADPH, and 6 lM biliverdin reductase Ascorbate was omitted from the control system Reduction was initiated by the addition of ascorbate Other conditions were the same as those for the NADPH/DmDCPR system

Reaction of hemin bound to DmDHO by NADPH/DmDCPR

or sodium ascorbate in the presence of desferrioxamine Spectral changes were recorded at 30C between 350 and

750 nm We used three electron donor systems, NADPH/ DmDCPR, ascorbate, and H2O2 The standard reaction mixture for the NADPH/DmDCPR system consisted of

10 lM DmDHO–hemin complex, 0.22 lM DmDCPR and

1 mMdesferrioxamine in a final volume of 1.5 mL 50 mM potassium phosphate buffer (pH 7.4) After 3 min preincu-bation, the reaction was started by the addition of 20 lL

10 mMNADPH (final concentration, 0.13 lM) The ascor-bate reaction mixture contained 10 lM DmDHO–hemin complex and 1 mM desferrioxamine in a final volume of 1.5 mL 50 mMpotassium phosphate buffer (pH 7.4) After

3 min preincubation, the reaction was initiated by the addi-tion of 20 lL 1M sodium ascorbate (final concentration,

13 lM) The HO system consisted of 10 lM DmDHO–

Trang 4

hemin complex in a final volume of 1.5 mL 50 mM

potassium phosphate buffer (pH 7.4) After 3 min

preincu-bation, the reaction was started by the addition of H2O2in

water (final concentration 36 lMor 300 lM) The

concen-tration of H2O2in the original aqueous reagent solution was

determined spectroscopically using a value of 43.6M )1Æcm)1

for the absorption coefficient at 240 nm [34]

EPR spectroscopy

EPR measurements were performed using a Bruker E500

spectrometer, operating at 9.35–9.55 GHz, with an Oxford

ESR 900 liquid helium cryostat The15NO-bound form of

the heme–DmDHO complex was prepared by adding

dithionite to the argon-saturated protein solution,

contain-ing Na15NO2, in an EPR tube

Detection of CO

To detect CO produced during the DmDHO reaction

supported by NADPH/DmDCPR, myoglobin (H64L), a

mutant with high affinity for CO [35], was used The

reaction solutions contained 16 lM hemin–DmDHO

com-plex, 1.6 lM DmDCPR, and 300 lM NADPH in 1.5 mL

50 mM potassium phosphate buffer (pH 7.4) Myoglobin

mutant H64L, at a final concentration of 7.5 lM, was

included in the test solution After the addition of NADPH

to both cuvettes, the spectrum was recorded at 4 min

intervals between 350 and 750 nm

HPLC analysis of DmDHO reaction products

The DmDHO reaction products of either NADPH/

DmDCPR or ascorbate were directly subjected to a

Supelclean LC-18 solid-phase extraction column,

precondi-tioned with 400 lL acetonitrile followed by 400 lL 0.1M

Tris/HCl buffer (pH 7.4) The product of the DmDHO

reaction with H2O2was loaded on the same column after

hydrolytic conversion into biliverdin The column was

washed with acetonitrile/water (1 : 9, v/v), and green

pigment was then eluted with acetonitrile/water (1 : 1,

v/v) This was lyophilized, and the residue dissolved in 5%

HCl/methanol for esterification at 4C overnight Water

was added to the esterified product, and green pigment was

extracted with chloroform The chloroform solution was

washed with water and then analyzed by HPLC on a

column of Capcell Pak C18 (SG 120, 4.6· 150 mm)

pre-equilibrated with degassed acetonitrile/water (3 : 2, v/v) at a

flow rate of 1 mLÆmin)1 The eluate was monitored at

310 nm The biliverdin dimethyl ester standards were eluted

in the order biliverdin IXa (18.2 min), IXd (19.7 min), IXb

(21.1 min), and IXc (31.1 min)

Other procedures

Sequence translation and sequence alignment were

per-formed using the WISCONSIN PACKAGE from the Genetic

Computer Group (Madison, WI, USA) and CLUSTAL W

multiple sequence alignment program at the EBI

(EMBL-EBI) H64L protein, a mutant of myoglobin, was purified

by published methods [36] Hemin concentrations were

measured by the method of Paul & Theorell [37], and

protein concentrations by the Lowry method using BSA as standard [38]

Results and Discussion

Characterization of DmHO deduced from the nucleotide sequence of cDNA

Both the full length (DmHO) and truncated (DmDHO) enzymes were obtained from adult D melanogaster polyA-rich RNA by the RT-PCR method The deduced amino acid sequences were the same as reported originally in the SwissProt Database (Q9VGJ9) with one exception; position

50 was not isoleucine but phenylalanine We think that Phe50 is more likely to be correct because: (a) Phe50 was coded in our three DNA fragments obtained by PCR using different template cDNA which was independently synthes-ized with oligo(dT), random, and gene-specific primers, respectively; (b) Phe37 in mammalian HO-1, which corres-ponds to Phe50 in DmHO, has an important role in the interaction with the a-meso edge of heme [39,40] and is conserved at the corresponding position of most HOs isolated from other species

Sequence comparisons by FASTA searching show that DmHO is 32.4% and 30.3% identical in amino acid sequence with rat HO-1 and rat HO-2, respectively (Fig 1) Sequence alignment analysis indicated that DmHO contains

a large catalytic domain at the N-terminus and a small hydrophobic domain at the C-terminus This structure is similar to mammalian HOs but different from bacterial, algal, and cyanobacterial HOs which lack the hydrophobic domain Moreover, the Swiss-model project (first approach mode) suggests that the overall structure of DmHO is similar to that of mammalian HO-1 In rat HO-1, His25 works as the proximal ligand of heme iron The His39 residue of DmHO corresponds to His25 of rat HO-1 and therefore is likely to be the proximal ligand The crystal structure of human HO-1 [39] shows that Thr21, Glu29 and Phe207 are on the proximal side of the heme In DmHO, Thr35 corresponding to Thr21 of HO-1 is conserved, but the other two amino acid residues are not The crystal structure of HO-1 also shows that the backbone atoms of the two glycine residues, Gly139 and Gly143, which are highly conserved among the known sequences of HOs, directly contact the heme [39,40] In the DmHO sequence, Gly143 is present, but Gly139 is replaced by alanine, as in the sequence of Arabidopsis HO [17] Site-directed muta-genesis studies revealed that Asp140 is involved in the oxygen activation mechanism in mammalian HO-1 [41,42], but this amino acid residue is not found in DmHO These features of DmHO suggest that, although the ternary structure of DmHO is similar to that of mammalian HO-1, the structure of the heme pocket is somewhat different Expression and purification of DmHO and DmDHO

To obtain the full length and truncated forms of recombin-ant DmHO, two expression plasmids, pMWDmHO and pMWDmDHO, were constructed E coli strain BL21(DE3) transformed with pMWDmHO expressed a protein in the membrane fraction which gives a strong 34 kDa band on SDS/PAGE In contrast, E coli harboring pMWDmDHO

Trang 5

expressed a soluble 32 kDa protein mainly in the soluble

fraction Molecular sizes of 34 kDa and 32 kDa are in

agreement with the calculated values of 34 112 Da for full

length DmHO and 31 777 Da for DmDHO These

obser-vations indicate that the C-terminal hydrophobic sequence

composed of 21 amino acid residues acts as an anchor to

membranes, similar to rat HO-1 [43,44] The truncated

forms of mammalian HOs, in which the hydrophobic

membrane-binding domains are removed, fully retain

heme-degrading activity [2,3] Therefore, we presumed that the

truncated form of DmHO also retains its activity As

described below, DmDHO is a soluble, catalytically active

protein and therefore we used only DmDHO in this study

The expression of DmDHO by culturing the transformed

E coli cells at 37C resulted in an accumulation of the

expressed protein mostly in inclusion bodies However,

culturing the transformed bacteria at 37C then 20 C as

described in Experimental procedures increased significantly

the yield of the recombinant protein in the soluble fraction

Expression of DmDHO, however, did not turn the culture

medium green This phenomenon is distinct from that

observed for E coli cells expressing mammalian, bacterial,

and cyanobacterial HOs and raises questions about the

heme-degrading activity of DmDHO

We purified the expressed DmDHO from the soluble

fraction by ammonium sulfate fractionation and

subse-quent column chromatography on Sepahdex G-75,

DE-52 and hydroxylapatite The purified DmDHO gave

a 32 kDa band with  95% purity on SDS/PAGE

(lane 2 in Fig 2) About 25 mg protein was obtained

from 1 L culture

Expression and purification of DmDCPR

Cultured E coli cells transformed with pMWDmDCPR

were light yellow caused by constitutive flavins of

DmDCPR During purification, we used this color along

with the 72 kDa band on SDS/PAGE for detecting

DmDCPR The purification procedures involved ammo-nium sulfate fractionation and column chromatography on DE-52 and 2¢5¢-ADP Sepharose 4B The purified fraction showed a single band of 72 kDa (lane 3 in Fig 2), similar to the calculated value of 71 740 Da The 2,6-dichloroindo-phenol-reducing activity of purified DmDCPR was similar

Fig 1 Amino acid sequence of DmDHO

compared with reported DmHO, rat HO-1 and

rat HO-2 * indicates positions that have a

single, fully conserved residue : indicates that

one of the strong groups is fully conserved.

indicates that one of the weaker groups is

fully conserved.

Fig 2 SDS/PAGE of the purified DmDHO and DmDCPR Lane 1, Molecular mass marker; lane 2, 2 lg p urified DmDHO; lane 3, 2 lg purified DmDCPR.

Trang 6

to that of purified rat CPR About 10 mg protein was

obtained from 1 L culture

Catalytic activity of DmDHO

As mentioned above, expressed DmDHO in E coli cells did

not turn the color of host cells green, so that we measured

the ability of DmDHO to catalyze the conversion of hemin

into biliverdin in vitro We used NADPH/DmDCPR and

ascorbate as reducing reagents and biliverdin IXa reductase

to reduce the biliverdin IXa produced by DmDHO to

bilirubin Table 1 suggests that DmDHO does degrade

hemin to biliverdin IXa in the presence of each of the

reducing systems, indicating that DmHO of fruit fly is a real

HO Interestingly, the specific activity of heme breakdown

was very low, almost one-quarter that with ascorbic acid,

although DmDCPR equivalent to one-fifth of DmDHO was

used In the case of rat HO-1, despite using rat CPR

equivalent to about one-thirtieth of rat HO-1, the activity of

heme degradation was half that seen in the ascorbate system

[45] This suggests that effective electron transfer does not

occur from DmDCPR to DmDHO

With rat HO-1, heme breakdown to biliverdin in the

presence of ascorbate is accelerated by desferrioxamine, a

ferric iron chelator, because in that system the final product

is not biliverdin but its precursor, ferric biliverdin, bound to

HO-1 protein [46] Therefore, we assayed DmDHO activity

in converting heme into bilirubin via biliverdin IXa in the presence of desferrioxamine As a result, the conversion activities with addition of either NADPH/DmDCPR or ascorbate increased by about eightfold and fourfold, respectively This suggests that spontaneous iron release from the ferric biliverdin–DmDHO complex in both systems

is slow The specific activity of DmDHO was highest in the ascorbate system in the presence of desferrioxamine but still only about one-quarter that of rat HO-1 As described below, HPLC analysis showed that 75% of the total biliverdin produced by DmDHO is the IXa isomer As biliverdin IXa reductase has a preference for the a-isomer as substrate [47], the total yield of biliverdin is significantly underestimated if measured as the amount of bilirubin IXa eventually formed Recently it was reported that coupled oxidation of myoglobin with ascorbic acid is mediated by exogenous peroxide generated by reaction of ascorbate with oxy-myoglobin, because the reaction is inhibited by catalase [48] In the case of DmDHO, inclusion of 10 lMcatalase had

no effect, clearly showing that the DmDHO reaction does not depend on exogenous peroxide

Properties of the heme–DmDHO complex All HOs so far reported bind heme stoichiometrically to form stable complexes with absorption spectra resembling those of myoglobin Like other HOs, DmHO also binds hemin to form a 1 : 1 stoichiometric complex (inset of Fig 3) To isolate this complex, we added excess (twofold) hemin to DmDHO and chromatographed the mixture on DE-52 or hydroxylapatite However, we obtained only DmDHO without hemin, indicating weak binding of hemin

to DmDHO In fact, from the hemin titration, we obtained a value of 27 ± 3 lMfor the heme dissociation constant (Kd) This value is significantly higher than those for HmuO (2.5 ± 1 lM) [12] and human HO-1 (0.84 ± 0.2 lM) [49] Figure 3 shows the optical absorption spectra of purified DmDHO titrated with 1 molar equivalent of hemin The ferric form of the DmDHO–heme complex has a broad Soret band with a peak at 390 nm and a smaller peak at

602 nm (solid line) As previously reported, the ferric heme

Table 1 Activities of purified DmDHO HO activity was determined

from the initial rate of bilirubin formation with NADPH/DmDCPR or

sodium ascorbate systems in the absence/presence of desferrioxamine

and the presence of biliverdin reductase All measurements were

per-formed in triplicate Values are mean ± SD.

Reducing system

Bilirubin formation [nmolÆ(mg protein))1Æh)1] –Desferrioxamine +Desferrioxamine NADPH/DmDCPR 32 ± 1.2 250 ± 8

Sodium ascorbate 138 ± 5 543 ± 10

Fig 3 Absorption spectra of various forms of the DmDHO–heme complex ––, oxidized form; ÆÆÆÆ, reduced form; - - -, CO-bound form Inset, difference titration of DmDHO with hemin Precise procedures are described in Experimental procedures The increments in absorbance as the difference at 412 nm were plotted, because the difference was maximum

at this wavelength.

Trang 7

iron in the rat HO-1–hemin complex at neutral pH is

six-coordinate, high spin, and the Soret maximum undergoes a

red shift with increasing pH, having an apparent pKavalue

of 7.6 [50] In contrast, the Soret maximum of the DmDHO–

hemin complex was not influenced by increasing the pH

to 10.0

We assumed that the ferric heme iron of the complex was

not in the six-coordinate state, presumably lacking the water

molecule at the distal site To confirm this, we carried out an

EPR study As shown in Fig 4, the EPR spectrum of the

hemin–DmDHO complex exhibits a highly rhombic,

high-spin state of hemin, showing pronounced difference from

that of the hemin complex of cyanobacterial heme

oxy-genase isoform-1, Syn HO-1, which was determined to be in

a six-coordinate high-spin state with a distal water molecule

and a proximal histidine [16] The lower field feature of the

spectrum further suggests that the ligand field around the hemin molecule is inhomogeneous, implying that orienta-tion of hemin in the DmDHO heme pocket is unequal The highly rhombic feature of the ferric heme–HO complexes is common to the point-mutated HOs of proximal histidine (data not shown) and to the five-coordinated a-hydro-xyhemin complex of HO-1 [2] Contrary to the sequence-based expectation, the spectrum of the ferrous15NO-bound heme–DmDHO complex is typical of penta-coordinated

15NO–heme complexes, differing from that of Syn HO-1, which is a hexa-coordinate15NO–heme complex exhibiting the triplet hyperfine splitting due to the nuclear spin of one

of the nitrogen nucleus of an imidazole of a histidine residue trans to the 15NO [16] (Fig 5) The hemin–DmDHO complex in alkaline solution (pH 10.0) does not show the spectrum of a typical hydroxide-coordinated low-spin form (data not shown) This is in accord with both the result of optical spectra and the revealed coordination structure of hemin without proximal histidine Accordingly, EPR results identify the hemin in the DmDHO complex to be uncoor-dinated by the protein residue, which is markedly different from other known hemin–HO complexes Reduction of the ferric heme with sodium dithionite under nitrogen gas yielded a ferrous form with a Soret band at 428 nm and a small peak at 559 nm (Fig 3, dotted line) After introduc-tion of CO, the ferrous form changed to a ferrous–CO form with a Soret maximum at 420 nm and two small peaks at

538 and 568 nm in the visible region (Fig 3, broken line)

To exchange the gas phase in the solution, the solution was quickly passed through a spin column of Sephadex G-25 in air The resulting solution exhibited a new spectrum with a Soret peak at 410 nm and two small peaks at 538 nm and

575 nm (data, not shown), indicating that the CO form was converted into the oxy form This oxy form was gradually turned into a ferric complex with an auto-oxidation rate (Kobs) of 3.5· 10)3s)1 This value is much higher than that

of rat HO-1 (0.14· 10)3s)1) and comparable to those of some mutants, in which the hydrogen-bonding network to stabilize oxygen bound to iron is thought to be weak [42] Table 2 shows optical absorption data for the heme– DmDHO complex

Reaction of hemin bound to DmDHO by NADPH/DmDCPR or sodium ascorbate

in the presence of desferrioxamine

As desferrioxamine increased biliverdin formation from hemin in both the NADPH/DmDCPR and ascorbate systems by facilitating the release of iron from the ferric biliverdin–DmDHO complex, we measured the degradation

of hemin bound to DmDHO in the presence of desferri-oxamine As depicted in Fig 6A, the addition of NADPH

Fig 4 EPR spectra of the ferric DmDHO and Syn HO-1 complexes at

neutral pH Both spectra were obtained at 8 K, applied field

modula-tion frequencies, 100 kHz, field modulamodula-tion amplitude, 10 G, and

microwave power, 1 mW.

Fig 5 EPR spectra of the ferrous15NO-bound forms of the heme–

DmDHO and Syn HO-1 complexes Both spectra were obtained at

20 K, applied field modulation frequencies, 100 kHz, field modulation

amplitude, 2 G, and microwave power, 0.2 mW.

Table 2 Optical absorption data for the heme–DmDHO complex.

k max (Soret) (em M )1 Æcm)1) k max (visible) Ferric form 390 (70) 602 Ferrous deoxy form 428 (80) 559

CO form 420 (163) 538, 568 Oxy form 410 (72) 537, 575

Trang 8

to the reaction solution (solid line I) initiated heme

degradation The spectrum recorded after 10 min (dotted

line) shows a red-shifted Soret maximum and two peaks at

538 and 575 nm in the visible region, indicating formation

of an oxy form Formation of the oxy form is faster than its

further degradation reaction, and loss of the Soret band was

relatively slow The spectrum recorded after 120 min

(broken line) has a broad absorption centered at 670 nm,

showing the conversion of hemin into biliverdin This is

supported by a decrease in absorbance around 670 nm and

concomitant increase near 460 nm due to bilirubin after

addition of biliverdin reductase (solid line II)

We also measured the spectral change in ascorbic

acid-supported heme degradation in the presence of

desferri-oxamine The spectrum in Fig 6B recorded 5 min after the

addition of sodium ascorbate (dotted line) shows that heme

degradation proceeded faster than in the presence of

NADPH/DmDCPR, consistent with the results from the catalytic activity assay This spectrum also has small peaks around 537 and 575 nm attributable to the oxy complex The spectrum recorded 30 min after the initiation of the reaction (broken line) shows two broad bands centered near

380 and 670 nm, indicative of slow biliverdin formation Again, after addition of biliverdin reductase and NADPH, a decrease in absorbance around 670 nm and concomitant increase near 460 nm were observed (solid line II) Comparison between the spectral intensities at 670 nm of the final product of both reducing systems suggests that about twice as much biliverdin is formed in the ascorbate system as in the NADPH/DmDCPR system We think that this is partly due to CPR-mediated heme degradation leading to nonbiliverdin products [51,52] In fact, we observed that about 40% of hemin was lost 120 min after incubation of 2.6 lM hemin with 1.2 lM DmDCPR and

300 lM NADPH at 30C As the affinity of heme for DmDHO is low, some of the substrate may be degraded by DmDCPR, making it unavailable for the DmDHO reaction

Reaction of the hemin bound to DmDHO by sodium ascorbate under O2and CO

With rat HO-1, hemin bound to enzyme is converted into ferrous–CO forms of verdoheme under O2and CO, and the reaction stops at this stage because CO stops the further reaction of verdoheme to ferric-biliverdin [53] To detect the ferrous–CO forms of the verdoheme–DmDHO complex, we carried out similar experiments The spectrum (dotted line in Fig 7) recorded 3 min after the start of the reaction has three peaks at 538, 568, and 602 nm in the visible region; the former two peaks are due to the CO-bound form and the latter peak to the ferric form of the hemin–DmDHO complex However, we were unable to detect a peak around

640 nm attributable to the ferrous–CO form of verdoheme The broken line is a spectrum recorded 40 min after the start of the reaction Again, absorption around 640 nm was not observed, but broad absorption in the red region increased, indicating biliverdin formation DmDHO shares several mechanistic features with other HOs, including CO formation, and therefore we believe that verdoheme is an intermediate in the DmDHO reaction We assume that verdoheme formation from the oxy form of the heme– DmDHO complex is slower than conversion of verdoheme into ferric biliverdin, which frustrates detection of the ferrous–CO form of verdoheme

Reaction of the hemin–DmDHO complex with H2O2

In mammalian HO-1, a ferric hydroperoxy species is an active intermediate in the first oxygenation step[54–56]

H2O2 hydroxylates heme at the a-meso position to form a-meso-hydroxyhemin, which is then converted into verdo-heme in the presence of O2[57] Therefore, we investigated whether H2O2can support the conversion of hemin bound

to DmDHO to verdoheme On addition of 3.6 molar equivalents of H2O2, the Soret band at 390 nm decreased gradually accompanied by a very small increase around

685 nm (data not shown) When 30 equivalents of H2O2 were used, a rapid decrease in the Soret band was observed However, the intensity of the absorption of the final reaction

Fig 6 Reaction of hemin bound to DmDHO by NADPH/DmDCPR or

sodium ascorbate in the presence of desferrioxamine (A) –– I, spectrum

of the complex of hemin and DmDHO; ÆÆÆÆ, spectrum 10 min after the

addition of NADPH to start the reaction; - - -, 120 min after the

reaction; –– II, after the addition of biliverdin reductase Inset,

enlarged spectra between 450 and 750 nm (B) –– I, spectrum of the

complex of hemin and DmDHO; ÆÆÆÆ, spectrum 5 min after the addition

of ascorbate to start the reaction; - - -, 30 min after the reaction; –– II,

after the addition of biliverdin reductase and NADPH Inset, enlarged

spectra between 450 and 750 nm.

Trang 9

product around 685 nm was almost the same as when 3.6

equivalents were used HPLC analysis showed that the

amount of biliverdin formed was only 0.15% of that formed

in the ascorbic acid/desferrioxamine-supported system

(Fig 8C)

These observations suggest that H2O2oxidized

DmDHO-bound heme to fragmentation products rather than to

verdoheme Presumably, in the first stage of the DmDHO

reaction, a hydroperoxy species is the active oxygen species,

by analogy with mammalian HO-1, and this species is

formed by binding of H2O2to the ferric iron of the hemin–

DmDHO complex We do not know why

verdohemo-chrome is not formed in the H2O2-supported DmDHO

reaction Interestingly, a mutant of human HO-1, D140A,

has similar properties [41]

Detection of CO during the DmDHO reaction

Difference absorption spectroscopy in the presence of

mutated myoglobin, H64L, which has a high affinity for

CO, was used to detect CO formed during the NADPH/

DmDCPR-supported reaction The Soret band of

myo-globin was monitored at 4-min intervals after the addition

of NADPH to both the sample and reference cuvette As

depicted in Fig 9, the myoglobin Soret band shifted from

393 to 425 nm with the appearance of a/b bands at 568 and

538 nm and A425increased, indicating reduction of the

ferric form of myoglobin to the ferrous form by the

NADPH/DmDCPR system This was followed by CO

binding to yield the ferrous–CO form, the authentic

absorption spectrum of which is depicted in inset of

Fig 9 This experiment clearly demonstrates CO formation

during heme degradation by DmDHO

HPLC analysis of the DmDHO reaction products

HPLC analysis showed that the biliverdin formed in both

the NADPH/DmDCPR/desferrioxamine and ascorbic

acid/desferrioxamine systems contained three isomers,

Fig 7 Reaction of hemin bound to DmDHO

by sodium ascorbate under O 2 and CO ––,

spectrum of the complex of hemin and

DmDHO; ÆÆÆÆ, spectrum 3 min after the

addi-tion of ascorbate to start the reacaddi-tion; - - -,

40 min after the start of the reaction Inset,

enlarged spectra between 500 and 800 nm.

Fig 8 HPLC analysis of the reaction products of hemin bound to DmDHO The product analysis with HPLC was described in Experi-mental procedures (S) Standard mixture of biliverdin IXa, IXb, IXc and IXd dimethyl esters; (A–C) esterified products from NADPH/ DmDCPR, sodium ascorbate, and H O systems, respectively.

Trang 10

IXa, IXb, and IXd, accounting for 75%, 16% and 8%

of the total, respectively (Fig 8) This is unusual, because

other HOs exclusively generate biliverdin IXa, except for

Pig A of Pseudomonas aeruginosa, which forms both

biliverdin IXb and IXd [14] The crystal structure of

human HO-1 reveals a distal helix spanning the entire

width of the heme, which sterically prevents access of the

iron-bound hydroperoxy species to the b-meso, c-meso,

and d-meso carbon atoms [39] Thus, the iron-bound

hydroperoxy species can oxygenate only the

a-meso-carbon of heme, leading to the exclusive

a-meso-hydroxy-heme formation The formation of three isomers of

biliverdin by DmDHO implies that its heme pocket has a

different structure from those of mammalian HO-1 and

other a-specific HOs The EPR result suggesting the

existence of several types of hemin conformation in the

protein pocket is consistent with this non a-specific

production of biliverdin We expected that DmDHO

would produce the c-isomer of biliverdin because

biliver-din IXc is present in some species of Lepidoptera

However, we detected only trace amounts of the

c-isomer in our in vitro studies of the soluble recombinant

enzyme

Concluding remarks

We cloned a cDNA for D melanogaster homologous to

mammalian HOs and constructed a bacterial expression

plasmid of a truncated, soluble enzyme, DmDHO Purified

recombinant DmDHO forms an enzyme–substrate complex

with a stoichiometric amount of heme and catalyzes heme

degradation to biliverdin isomers, CO and iron, although

the specific activity was very low, in the presence of

appropriate reducing systems These features are similar to

those of other HOs, indicating that DmDHO is a true heme

oxygenase in fruit fly

Despite these similarities, DmDHO is distinctly different

from other HOs (a) Unlike other HOs, the hemin–

DmDHO complex is not in the six-coordinate high-spin

state with a histidine residue as the proximal ligand and

the iron of heme was not involved in forming the heme– DmHO complex (b) H2O2 does not support DmDHO-dependent degradation of heme to verdoheme (c) CO– verdoheme cannot be detected during the catalytic reaction under oxygen and CO (d) In the final stage of the reaction, iron release from the ferric biliverdin–DmDHO complex is slow (e) The hemin catabolism of DmDHO is not a-specific and yields three isomers of biliverdin, IXa, IXb, and IXd Accordingly, we infer that the structure and hydrogen bonding of the DmHO active site is quite different from those of other HOs It is interesting to note that DmDHO was able to degrade heme to biliverdin, in spite of no direct binding of heme iron to the enzyme A similar but not identical observation was reported for a mutant of HmuO The H20A mutant in which His20 was replaced by Ala degraded hemin to verdoheme, a second intermediate of heme degradation [58] Further investiga-tion of the structure to understand the mechanism of heme breakdown is needed

Acknowledgements

The bacterial expression vector pMW172 was a gift from Dr K Nagai, MRC Laboratory of Molecular Biology, Cambridge, UK The expression plasmid for the myoglobin mutant, H64L was a gift from Professor J S Olson, Rice University We thank Dr A F McDonagh, University of California, San Francisco, for helpful comments on the manuscript This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture, Japan (14580641).

References

1 Tenhunen, R., Marver, H.S & Schmid, R (1969) Microsomal heme oxygenase Characterization of the enzyme J Biol Chem.

244, 6388–6394.

2 Yoshida, T & Migita, C.T (2000) Mechanism of heme degrada-tion by heme oxygenase J Inorg Biochem 82, 33–41.

3 Colas, C & OrtiZ de Montellano, P.R (2003) Autocatalytic radical reactions in physiological prosthetic heme modification Chem Rev 103, 2305–2332.

Fig 9 Detection of CO produced during DmDHO reaction The sample solution con-tained hemin–DmDHO complex, DmDCPR and H64L mutant of myoglobin Myoglobin was omitted from the reference solution The reaction was started by the addition of NADPH to both solutions The difference spectrum was recorded at 4-min intervals Inset: absorption spectra of various forms of H64L mutant of myoglobin ––, oxidized form; ÆÆÆÆ, reduced form; - - -, CO bound form.

Ngày đăng: 19/02/2014, 12:20

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm